Skip to main content

Canadian drug companies join forces to produce monkeypox vaccine

Share

Montreal-based biopharmaceutical company PnuVax and Ontario-based drug manufacturer Biolyse Pharma announced Wednesday that they have signed an agreement to mass produce a monkeypox vaccine.

The two companies say they have the capabilities to produce millions of doses nationwide.

The undertaking could add up to 50 employees per company.

Monkeypox is a highly contagious disease that can cause painful lesions.

About 1,000 cases have been reported in Canada to date.

-- This report by The Canadian Press was first published in French on Aug. 10, 2022. 

CTVNews.ca Top Stories

Here's why provinces aren't following Saskatchewan's lead on the carbon tax home heating fight

After Prime Minister Justin Trudeau said the federal government would still send Canada Carbon Rebate cheques to Saskatchewan residents, despite Saskatchewan Premier Scott Moe's decision to stop collecting the carbon tax on natural gas or home heating, questions were raised about whether other provinces would follow suit. CTV News reached out across the country and here's what we found out.

Stay Connected